Who is sponsoring NCT03265847?

NCT03265847 is sponsored by Johns Hopkins University.

What drugs are being tested in NCT03265847?

Interventions in NCT03265847: Culturally-tailored Safety Planning.

What condition does NCT03265847 study?

NCT03265847 studies Violence, Domestic, Violence-Related Symptom.

Is NCT03265847 still recruiting?

NCT03265847 is currently completed. Last updated 29 September 2020.

Last reviewed 2020-09-29 · How we verify

NCT03265847

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The weWomen and ourCircle Intervention for Immigrant, Refugee and Indigenous Women

Completed NA Last updated 29 September 2020

What this trial tests

NA trial testing Culturally-tailored Safety Planning in Violence, Domestic in 688 participants. Completed in 31 August 2020.

Timeline

19 December 2017

Primary endpoint
31 August 2020

31 August 2020

Quick facts

Lead sponsor	Johns Hopkins University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	688
Start date	19 December 2017
Primary completion	31 August 2020
Estimated completion	31 August 2020
Sites	1 location across United States

Drugs / interventions tested

Culturally-tailored Safety Planning

Conditions studied

Violence, Domestic — all drugs for Violence, Domestic →
Violence-Related Symptom — all drugs for Violence-Related Symptom →

Sponsor

Johns Hopkins University

Who can join

Adults 18 to 64, female only, with Violence, Domestic or Violence-Related Symptom. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the impact of administering culturally-specific versions of the Danger Assessment (DA) tool followed by the tailored safety planning/referral via use of internet/smartphone-based safety decision aid (SDA) on immigrant, refugee and indigenous women's empowerment, safety and mental health. Half of survivors will receive tailored safety planning/referral based on their level of risk assessed by the DA, while the other half will receive non-DA informed usual safety planning/referral.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

The weWomen and ourCircle randomized controlled trial protocol: A web-based intervention for immigrant, refugee and indigenous women with intimate partner violence experiences.
Sabri B, Njie-Carr VPS, Messing JT, Glass N, et al · · 2019 · cited 35× · PMID 30517888 · DOI 10.1016/j.cct.2018.11.013
Intimate Partner Violence and Electronic Health Interventions: Systematic Review and Meta-Analysis of Randomized Trials.
Linde DS, Bakiewicz A, Normann AK, Hansen NB, et al · · 2020 · cited 21× · PMID 33306030 · DOI 10.2196/22361

Verify or expand the search:

Other recruiting trials for Violence, Domestic

Currently open trials in the same condition.

NCT06650267 — Substance Misuse and Family Violence Treatment Fathers · Phase 2 · recruiting
NCT05768217 — Community Resiliency Collective Efficacy Intervention · NA · recruiting
NCT04235335 — Healing Circles: An Intervention for Canadian Indigenous Mothers & Children Affected by IPV · NA · recruiting

Other Johns Hopkins University trials

Trials by the same sponsor.

NCT06236542 — Tracheostomy Robotics and Cutting-edge Health Education for Airway Safety · NA · not yet recruiting
NCT07532252 — Daridorexant for Alcohol Use Disorder · Phase 2 · not yet recruiting
NCT06687655 — Impact of Exogenous Ketones on Sleep Apnea · Phase 1, PHASE2 · not yet recruiting
NCT07079111 — 3D Printed Occlusal Splints for Intraoperative Use · NA · not yet recruiting
NCT02998502 — The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03265847 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Johns Hopkins University
Last refreshed: 29 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03265847.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing